Pharvarians presented #deucrictibant data at the European Academy of Allergy and Clinical Immunology - EAACI Congress and the Eastern Allergy Conference this past weekend. We are grateful to the #HAE community for the continued #collaboration and support of #drugdevelopment. #TBT
Pharvaris’ Post
More Relevant Posts
-
What are the pros and cons of dual accreditation in both rheumatology and allergy immunology? Our latest guest, Dr. Bharat Kumar, gives us his insights. Listen → acrjournalsonair.org
-
The latest issue of Asthma Allergy Immunology (official journal of Turkish National Society of Allergy and Clinical Immunology) is now online. #asthmallergyimmunology Asthma Allergy Immunology https://lnkd.in/d2pFDEpg
-
-
Medical Strategy Executive & Servant Leader >>> Field Medical Insights | Medical Affairs | co-host of MSLead Chronicles
#medicalaffairs leaders, this episode is a must listen for your #msl team! You won’t regret it! Please be sure to share with your network! #mslvalueintheeyesoftheKOL
🎙 "Exploring MSL Value through the Eyes of a KOL" with our guest, Patrick Win, MD, top KOL in Allergy and Immunology is available now for download on all your streaming services. This is a DON'T MISS episode! YouTube: https://lnkd.in/gEzVSehM 🎧 Apple Podcasts https://lnkd.in/gMkAbeVu Spotify https://lnkd.in/gx9S_U3Y iHeart Radio https://lnkd.in/gfpyvdwH
-
-
Open Access: Transitional care of adolescents and young adults with asthma and allergy—The healthcare professional perspective First and corresponding author: Maria Ödling Read the article here: doi.org/10.1111/all.16047 In 2020, both the European Academy of Allergy and Clinical Immunology (#EAACI) and the Swedish Paediatric Society published guidelines for health care professionals (HCPs) to support the transitional care of adolescents and young adults with #asthma and #allergy. Odling et al. report the findings of a web-based survey conducted to determine, if HCPs were adhering to the guidelines in their practice. #Allergy_journal Read more articles published on clinical #immunology here: https://lnkd.in/ex3Y69tY https://lnkd.in/dv4NzwRx is a link to the March issue table of contents.
-
-
Meet the Researchers Behind the Science! Allergy-TV features video abstracts created by the authors of our latest articles. Get insights directly from the experts on groundbreaking research in allergy, asthma, and immunology. Why Subscribe? - Direct insights from leading researchers - Easy-to-understand summaries of cutting-edge research - Stay updated on the latest advancements 👉 Subscribe to Allergy-TV and stay at the forefront of allergy research: https://lnkd.in/g7V4h4nd #AllergyResearch #Asthma #Immunology #ScientificJournal #Allergy_journal
-
-
Collaborating with pharma to educate HCP's, improving patient outcomes and elevating the quality of healthcare globally.
Day 2 of #EAACI2024; Exciting to see all the latest scientific developments and familiar faces. The upcoming journal is going to be very interesting read indeed! #allergy #immunology European Academy of Allergy and Clinical Immunology - EAACI
-
-
Rates of new peanut allergy and discontinuation after introduction appeared low in a cohort of high-risk infants. https://lnkd.in/eUCtVF9u
-
Helping pharmaceutical companies educate and engage HCPs Globally to improve patient outcomes - all views expressed here are my own | Also interested in Stocks, Start-ups, Investing & Property
Are you attending the 18th International Conference on Allergy, Asthma, and Immunology in Zurich, Switzerland, on January 11-12, 2024? EMJ Allergy & Immunology wants to feature YOUR posters, abstracts, and sessions from ICAAI! 📩 Drop me a quick message, and I'll email you all the details. Let's showcase your insights and contribute to the advancement of Allergy and Immunology knowledge together! #ICAAI2024 #AllergyImmunology #MedicalConference #ResearchShowcase #allergy #ICAAI #Immunology #Asthma
SVP of Growth & Innovation | Dedicated to Life Sciences | Digital & Technology Enthusiast | HBA member
2moWay to go Justin & team! Congratulations on your data presentation! 🚀